Two of the vaccines we have for COVID-19 have the distinction of being the first mRNA vaccines to see widespread use in ...

Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...

The strategy carries risks, because support for Kennedy is cratering and polls show voters care more about reducing health ...

A deep learning framework combines convolutional and bidirectional recurrent networks to improve protein function prediction from genomic ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

After a period defined by its COVID-19 vaccine, BioNTech is reasserting its presence in the oncology arena. A recent regulatory milestone and a significant upgrade from a major investment bank are ...

As we age, the immune system gradually declines in function, leaving the body more vulnerable to disease. Scientists have discovered a new way to rejuvenate a key component of immune function, ...

Qiagen was the second-best performer, with a weekly return of 16.92%. The 3-star stock has gained 10.76% over the last three ...